|FOOD AND DRUG
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
February 4, 1998
Caffeine and Sod
Caffeine and Sodium Benzoate Injection, USP,
0.5 g/2 ml, Rx sterile solution for
intramuscular or slow intravenous
administration to treat respiratory depression
associated with overdosage with CNS depressant
drugs. NDC #11098-505-02.
Taylor Pharmaceuticals, Decatur, Illinois.
Manufacturer, by letter dated November 25,
1997. Firm-initiated recall ongoing.
Nationwide and Canada.
366 cartons were distributed; firm estimated
that 33 percent of product remained on market
at time of recall initiation.
Mislabeling - The ampule label and shelf
carton fail to list the strength of the
caffeine and sodium benzoate. Also, the shelf
carton lists the ampule size as 2 ml on the
principle display panel and 1 ml the end flap.
Arabia, Spain, Sweden, Switzerland, United